STaiMIC

The Strategic Translational AI and Multiomics Innovation Center is building the multiomics research infrastructure layer for precision medicine across the Mediterranean and Middle East.

Four components work as one integrated ecosystem.

The Hub: multiomics research infrastructure anchored in Basilicata's EU Convergence Region.
The Programmes: one shared pipeline, activated through disease verticals as grants and partnerships land.
The Platform: clinical AI and validated reference datasets.
The STaiMIC Institute: applied-AI training for practising clinicians, healthcare staff, and students.

Coalition infrastructure, four partnership pathways: research agencies, pharma and medtech, clinical networks, strategic investors.

We Are Building Our Expert Community

STaiMIC is assembling the human infrastructure to match the ambition of its science.

Scientific Advisory Board (SAB) — We are inviting internationally recognised researchers and clinicians in multiomics, translational medicine, precision oncology, cardiovascular genomics, rare disease, federated data governance, and clinical AI to help shape our scientific direction.
Industry Advisory Group (IAG) — We are forming a senior advisory group from pharma, medtech, digital health, and health investment to connect our pipeline to the right partners, markets, and regulatory pathways.
Fractional and Project-Based Experts — We are hiring on a flexible, project basis. We are looking for expertise in: bioinformatics, biostatistics, data science, data engineering, multiomics integration, federated data systems, clinical study design, and EU regulatory affairs (MDR, IVDR, AI Act).

Interested? Contact us at admin@staimic.it — subject line: SAB, IAG, or Fractional.

This page, alongside the full STaiMIC website, will be published at the completion of legal entity formation, scheduled May/June 2026 in Basilicata.